FDA Inspection
Brigham and Women's HospitalBrigham and Women's Hospital – FDA Inspection, Jun 22, 2026
Record Details
This FDA Inspection record concerns Brigham and Women's Hospital, with an inspection on June 22, 2026, issued by the New England District Office, covering human drugs.
View Company Profile
ID · b39d19f7-4a4d-46f2-b2ff-e241e957016e
Inspection Facts
- Inspection number
- 1323146
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Brigham and Women's Hospital
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 22, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 10, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| August 15, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Brigham and Women's Hospital
- FDA Inspection 1203279 - 2023-04-11
- FDA Inspection 1152063 - 2021-09-16
- FDA Inspection 1100702 - 2019-08-22
- FDA Inspection 953620 - 2015-12-10
- FDA Inspection 891621 - 2014-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.